drugset
drugset / Trial / NCT00005931

SU5416 in Patients With AIDS-Related Kaposi's Sarcoma Who Have Not Responded to Treatment

NCT00005931 ↗

Phase 2 Completed 30 enrolled SUGEN
Treatment

Summary

The purpose of this study is to test the effectiveness of SU5416 in patients with AIDS-related Kaposi's sarcoma (KS).

Timeline

Start
—
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject semaxanib Small molecule — Intravenous

Indications

HIV infectious disease Kaposi's sarcoma